BATS BZX Real-Time Price
As of 11:12am ET
| +0.30 / +0.80%|
The 25 analysts offering 12-month price forecasts for GlaxoSmithKline have a median target of 45.03, with a high estimate of 52.24 and a low estimate of 35.10. The median estimate represents a +19.46% increase from the last price of 37.69.
The current consensus among 26 polled investment analysts is to Hold stock in GlaxoSmithKline. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.